Chikashi Nakanishi

Molecular Biology · 2005

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Chikashi Nakanishi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Adams
  2. M. Hayden
  3. M. Karin
  4. Scott W. Lowe

Who trusts Chikashi Nakanishi overall

  1. Véronique Baud
  2. Adrian C. Begg

Papers from Chikashi Nakanishi's perspective

Ordered by how strongly the researchers Chikashi Nakanishi trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A phase 2 study of bortezomib in relapsed, refractory myeloma. (New England Journal of Medicine)
  2. Signaling to NF-kappaB. (Genes & Development)
  3. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB (Nature)
  4. The proteasome: a suitable antineoplastic target (Nature Reviews. Cancer)
  5. The two NF-κB activation pathways and their role in innate and adaptive immunity
  6. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. (Annual Review of Immunology)
  7. NF-κB functions as a tumour promoter in inflammation-associated cancer (Nature)
  8. Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. (Journal of Clinical Oncology)
  9. Intrinsic tumour suppression (Nature)
  10. Signal transduction by tumor necrosis factor and its relatives. (Trends in Cell Biology)

Their papers